NEXTERONE Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Nexterone patents expire, and when can generic versions of Nexterone launch?
Nexterone is a drug marketed by Baxter Hlthcare and is included in one NDA. There are two patents protecting this drug.
This drug has fifty-two patent family members in twenty countries.
The generic ingredient in NEXTERONE is amiodarone hydrochloride. There are fifteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nexterone
A generic version of NEXTERONE was approved as amiodarone hydrochloride by TEVA PHARMS on November 30th, 1998.
Summary for NEXTERONE
International Patents: | 52 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 110 |
Clinical Trials: | 3 |
Patent Applications: | 793 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for NEXTERONE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for NEXTERONE |
What excipients (inactive ingredients) are in NEXTERONE? | NEXTERONE excipients list |
DailyMed Link: | NEXTERONE at DailyMed |


US Patents and Regulatory Information for NEXTERONE
NEXTERONE is protected by two US patents.
Patents protecting NEXTERONE
Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Sulfoalkyl ether cyclodextrin compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Expired US Patents for NEXTERONE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Baxter Hlthcare | NEXTERONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 022325-001 | Dec 24, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Baxter Hlthcare | NEXTERONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 022325-001 | Dec 24, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Baxter Hlthcare | NEXTERONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 022325-003 | Nov 16, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
Baxter Hlthcare | NEXTERONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 022325-002 | Nov 16, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
Baxter Hlthcare | NEXTERONE | amiodarone hydrochloride | INJECTABLE;INJECTION | 022325-001 | Dec 24, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NEXTERONE
See the table below for patents covering NEXTERONE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 105288650 | Sulfoalkyl ether cyclodextrin compositions | ⤷ Try a Trial |
Hong Kong | 1219883 | 磺烷基醚環糊精組合物 (SULFOALKYL ETHER CYCLODEXTRIN COMPOSITIONS) | ⤷ Try a Trial |
Japan | 2012072160 | SULFOALKYL ETHER CYCLODEXTRIN COMPOSITION | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 03092590 | ⤷ Try a Trial | |
Slovenia | 2402008 | ⤷ Try a Trial | |
Australia | 646020 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |